Skandinaviska-Enskilda-Banken-Ab-Publ

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-07
Total Holdings
999
Total Value
20298308153
Accession Number
0001534653-25-000007
Form Type
13F-HR
Manager Name
Skandinaviska-Enskilda-Banken-Ab-Publ
Data Enrichment
97% identified
965 identified34 unidentified

Holdings

999 positions • $20.3B total value
Manager:
Search and click to pin securities to the top
Page 35 of 42
70435P102
Shares:23.9K
Value:$536.6K
% of Portfolio:0.0% ($536.6K/$20.3B)
Vera Therapeutics, Inc.
Shares:22.3K
Value:$535.4K
% of Portfolio:0.0% ($535.4K/$20.3B)
IDEAYA Biosciences, Inc.
Shares:32.5K
Value:$533.1K
% of Portfolio:0.0% ($533.1K/$20.3B)
JONES LANG LASALLE INC
Shares:2.1K
Value:$520.6K
% of Portfolio:0.0% ($520.6K/$20.3B)
ZIM Integrated Shipping Services Ltd.
Shares:35.6K
Value:$519.4K
% of Portfolio:0.0% ($519.4K/$20.3B)
IOVANCE BIOTHERAPEUTICS, INC.
Shares:155.7K
Value:$517.6K
% of Portfolio:0.0% ($517.6K/$20.3B)
MSA Safety Inc
Shares:3.5K
Value:$512.7K
% of Portfolio:0.0% ($512.7K/$20.3B)
Fluence Energy, Inc.
Shares:104.6K
Value:$506.6K
% of Portfolio:0.0% ($506.6K/$20.3B)
Viking Therapeutics, Inc.
Shares:20.7K
Value:$500.4K
% of Portfolio:0.0% ($500.4K/$20.3B)
GRANITE CONSTRUCTION INC
Shares:6.6K
Value:$497.6K
% of Portfolio:0.0% ($497.6K/$20.3B)
Veren Inc.
Shares:75.0K
Value:$496.5K
% of Portfolio:0.0% ($496.5K/$20.3B)
Bicara Therapeutics Inc.
Shares:38.0K
Value:$495.6K
% of Portfolio:0.0% ($495.6K/$20.3B)
AZEK Co Inc.
Shares:10.0K
Value:$488.9K
% of Portfolio:0.0% ($488.9K/$20.3B)
Sana Biotechnology, Inc.
Shares:289.3K
Value:$483.1K
% of Portfolio:0.0% ($483.1K/$20.3B)
SLM Corp
Shares:16.4K
Value:$482.8K
% of Portfolio:0.0% ($482.8K/$20.3B)
00922R105
Shares:21.4K
Value:$479.7K
% of Portfolio:0.0% ($479.7K/$20.3B)
Sigma Lithium Corp
Shares:45.7K
Value:$475.7K
% of Portfolio:0.0% ($475.7K/$20.3B)
Paramount Global
Shares:20.9K
Value:$474.6K
% of Portfolio:0.0% ($474.6K/$20.3B)
KalVista Pharmaceuticals, Inc.
Shares:40.9K
Value:$471.1K
% of Portfolio:0.0% ($471.1K/$20.3B)
GENMAB A/S
Shares:23.9K
Value:$467.7K
% of Portfolio:0.0% ($467.7K/$20.3B)